AGENDA

FRIDAY 6TH OCTOBER
08:00 Registration and coffee
Session 1
A thorough understanding of anatomy and tissue planes is paramount to avoiding adverse events. The 3 most common areas of fillers complications - periorbital, lips, and SMAS - are discussed and how to successfully treat them.
09:00 Introduction and welcome -  Lee Walker BDS
09:05
Post Hyaluronic acid recurrent eyelid edema: diagnosis, prevention and treatment 
 
09:25
SMAS: The Neglected Layer 
 
09:45
A Surgical-Nonsurgical Approach to a Lip Complication
 
10:05 Panel Discussion/ Q and A
10:30 Refreshments and Exhibition 
Session 2
The late and delayed events continue to be challenging to diagnose and treat.  This session revisits some basics and unpicks the details of actual cases, to navigate management planning.
11:00 Introduction
11:05
The Genetic Origin of Soft Tissue Fillers Adverse Events
 
11:25
Max Fax Rescue
 
11:45
Abscess - A Case Review from Diagnosis to Resolution
 
12:05 Panel Discussion/ Q and A
12:30 Lunch and Exhibition 
Session 3
Threads have become increasingly popular and adverse events are rarely discussed at meetings. This session covers complications with threads and three different approaches to management.
13:30 Introduction
13:35
Surgical Experience with Thread Brow-Lifting 
 
13:55
Looking Underneath the Skin: A Sonographic Approach to Thread Complications
 
14:15
Thread Lifts: Keeping Within the Lines 
 
14:35 Panel Discussion/ Q and A 
14:55 Refreshments and Exhibition
Session 4
For HA fillers, hyaluronidase can reverse most complications. What about non-dissolvable fillers? This session looks at cases with non-HA products and how they were managed.
15:25 Introduction
15:30
Managing an adverse PLLA reaction in HIV related Facial Lipoatrophy during the COVID19 Pandemic: A Complex Case Study
 
Sharron Brown RN & Jonathan Collier MD
15:50
CaHA Vascular Adverse Events: Developing a protocol to minimise risk of scarring
 
16:10
Complications and Management of Equine Collagen Injections in the Aestheic Field
 
16:30 Panel Discussion/ Q and A
17:00 END

 

SATURDAY 7TH OCTOBER
08:00 Registration and coffee
Session 1
Vision loss, whether temporary or permanent remains rare, but potentially catastrophic. Speakers present actual cases and explain the management which succeeded and the mechanisms involved. A new protocol is outlined.
09:00 Introduction
09:05
Published Blindness Reversals after HA filler injection – My own experience and the ANZ Blindness Consensus Paper Recommendations for bedside care in this catastrophic adverse event 
 
09:25
Delayed Visual Loss of Secondary to Vaso-Occlusive Retinopathy: Sometimes the lights come back on
 
09:45
A Case of Blindness - Lessons learned
 
10:05 Panel Discussion/ Q and A
10:30 Refreshments and Exhibition 
Session 2
Hyaluronidase continues to dominate resolving VAE, however, adjunctive treatments can potentially speed recovery and minimize long term complications.
11:00 Introduction
11:05
Necrosis Rescue: Are you Prepared for the Apocalypse?
 
11:25
VAE/VO Remedies - Everything other than Hyaluronidase
 
11:45
Considering Oxygen Therapy - No pressure 
 
12:05
When Hyaluronidase hits the headlines
 
12:25 Panel Discussion/ Q and A
12:45 Lunch and Exhibition 
Session 3
Using devices and imaging techniques can assist in the management of aesthetic complications. This section discusses the use of MRI, ultrasound, and energy based devices to ensure optimal outcomes.
13:45 Introduction
14:05
Dermal Filler: X-Ray Vision
 
14:25
Devices (and other stuff) to Treat Complications
 
14:45
Management of Polycaprolaptone (PCL) Associated Delayed Onset Nodules with the Help of Ultrasound Guided Injections
 
15:05
Ultrasound-guided complications - pitfalls and pearls
 
15:25 Panel Discussion/ Q and A 
15:45 Refreshments and Exhibition
Question Time
16:05 Audience questions brought to the panel for discussion
17:00 END - Evening Reception